Prevalence Trend Source: US Census / Alz. Assoc.
The $800B Burden Direct vs. Unpaid
Unpaid care valued at $413.5B (19.2B total hours)
Biological Hallmarks
Amyloid Beta Plaques
Hyperphosphorylated Tau
40% Modifiable Risk Factors Source: Lancet Commission
Memory Care Impact: Preserving Independence
Clinical Insight: Beyond cognitive scores, memory-care data focus on Functional Independence. Modern therapies have shown a significant slowing in the decline of daily activities such as dressing, bathing, and managing finances, granting families more “high-quality” time before high-acuity care is required.
Academic & Statistical Sources
• Alzheimer’s Association: 2025 Alzheimer’s Disease Facts and Figures (Prevalence and Costs).
• JAMA Neurology: Accuracy of p-tau217 Blood Tests for Alzheimer’s Diagnosis (2024-25 Reports).
• NEJM & iADRS Data: Preservation of Daily Functioning and Memory Quality in TRAILBLAZER-ALZ 2 trials.
• NIH Research Progress: 2025 Alzheimer’s Disease and Related Dementias Report.
